Trial · NCT02745119
Adverse events695
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 695
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Conjunctival haemorrhage | Eye disorders | Lampalizumab Q4W - Treatment-Naive | 17 | 145 | |
| other | Conjunctival haemorrhage | Eye disorders | Lampalizumab Q4W - Previously Treated | 17 | 274 | |
| other | Conjunctival haemorrhage | Eye disorders | Lampalizumab Q6W - Treatment-Naive | 12 | 146 | |
| other | Conjunctival haemorrhage | Eye disorders | Lampalizumab Q6W - Previously Treated | 20 | 277 | |
| other | Conjunctival haemorrhage | Eye disorders | All Participants | 66 | 842 | |
| other | Eye pain | Eye disorders | Lampalizumab Q4W - Treatment-Naive | 8 | 145 | |
| other | Eye pain | Eye disorders | Lampalizumab Q4W - Previously Treated | 8 | 274 | |
| other | Eye pain | Eye disorders | Lampalizumab Q6W - Treatment-Naive | 5 | 146 | |
| other | Eye pain | Eye disorders | Lampalizumab Q6W - Previously Treated | 11 | 277 | |
| other | Eye pain | Eye disorders | All Participants | 32 | 842 | |
| other | Nasopharyngitis | Infections and infestations | Lampalizumab Q4W - Treatment-Naive | 11 | 145 | |
| other | Nasopharyngitis | Infections and infestations | Lampalizumab Q4W - Previously Treated | 12 | 274 | |
| other | Nasopharyngitis | Infections and infestations | Lampalizumab Q6W - Treatment-Naive | 3 | 146 | |
| other | Nasopharyngitis | Infections and infestations | Lampalizumab Q6W - Previously Treated | 6 | 277 | |
| other | Nasopharyngitis | Infections and infestations | All Participants | 32 | 842 | |
| other | Fall | Injury, poisoning and procedural complications | Lampalizumab Q4W - Treatment-Naive | 11 | 145 | |
| other | Fall | Injury, poisoning and procedural complications | Lampalizumab Q4W - Previously Treated | 12 | 274 | |
| other | Fall | Injury, poisoning and procedural complications | Lampalizumab Q6W - Treatment-Naive | 5 | 146 | |
| other | Fall | Injury, poisoning and procedural complications | Lampalizumab Q6W - Previously Treated | 14 | 277 | |
| other | Fall | Injury, poisoning and procedural complications | All Participants | 42 | 842 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02745119/events